Reductions of Antipsychotic and Hypnotic Medications in Namaste Care

Journal of the American Medical Directors Association

Volumn 14, Issue 9, 2013, Pages 708-709

  Fullarton, Janet ^a   Volicer, Ladislav ^b  

^a Greenhills Care Home   (United Kingdom)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; HYPNOTIC AGENT; NEUROLEPTIC AGENT; QUETIAPINE; ZOLPIDEM; ZOPICLONE;

ALZHEIMER DISEASE; ANALGESIA; HUMAN; LETTER; LEWY BODY; LIFESPAN; NAMASTE CARE; PAIN ASSESSMENT; PARKINSON DISEASE; PATIENT CARE;

AGED; ANTIPSYCHOTIC AGENTS; DEMENTIA; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; QUALITY OF LIFE; THERAPEUTIC TOUCH;

EID: 84884156593     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2013.06.002     Document Type: Letter

References (3)

1. Van der Steen J.T., Ribbe M.W., Deliens L., et al. Retrospective and prospective data collectioncCompared in the Dutch End of Life in Dementia (DEOLD) Study. JPalliative Med 2012, in press.
2. Simard J. The End-of-Life Namaste Program for People with Dementia 2013, Health Professions Press, Baltimore, MD. 2nd ed.
3. Simard J., Volicer L. Effects of Namaste Care on residents who do not benefit from usual activities. Am J Alzheimers Dis Other Dement 2010, 25:46-50.